This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.

IFSO WC 2017

239818780

Only logged in users can watch the full video
A small part is available for preview

Only logged in users can watch the full video

New Scoring System Helps Guide Surgical Choice for Patients with Obesity and Diabetes

Dr. Aminian, Associate Professor of Surgery at the Cleveland Clinic, discusses a new method for selecting the most appropriate surgical technique for treatment of patients with type 2 Diabetes Mellitus (T2DM). He divides T2DM into 3 validated stages of severity and presents an online calculator (http://riskcalc.org/Metabolic_Surgery_Score)  that may help in the selection of the surgical procedure for each patient, thus enabling a more tailored treatment of obesity and T2DM. He emphasizes the importance of surgical intervention in early stages of T2DM in order to achieve sustainable results.

An international panel of experts from IFSO: Dr. Himpens (IFSO President), Dr. Cohen (Hospital Alemão Oswaldo Cruz, Brazil), Dr. Cummings (University of Washington, USA), Dr. Shikora (Brigham and Women’s Hospital, Boston, USA) and Dr. Lee (Min-Shen General Hospital, Taiwan) discuss Dr. Aminian’s lecture, highlighting the importance of the duration of T2DM on results, the importance of gastroesophageal reflux disease (GERD) on the choice of surgical technique compared with T2DM, and the possible future importance of C-peptide in metabolic surgery.

Dr. Lee from Taiwan discusses the results available on the Asian population compared to those presented by Dr. Aminian.

Finally, clinical cases are discussed in order to explain the use of the online calculator.